Revvity (RVTY) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Revvity (RVTY) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -159.32% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 7.86% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 14.74% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -27.15% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 57.67% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -44.49% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2.29% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.59% |
| 10 | Revvity | 12.62 Bn | 11.76 Bn | 387.66 Mn | -130.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -130.81% |
| Dec 28, 2025 | -58.59% |
| Sep 28, 2025 | -158.00% |
| Jun 29, 2025 | 92.61% |
| Mar 30, 2025 | 121.17% |
| Sep 29, 2024 | 104.27% |
| Jun 30, 2024 | 25.22% |
| Mar 31, 2024 | -100.49% |
| Oct 1, 2023 | -245.03% |
| Jul 2, 2023 | -230.96% |
| Apr 2, 2023 | 7,762.21% |
| Jan 1, 2023 | 394.85% |
| Oct 2, 2022 | -21.23% |
| Jul 3, 2022 | -2.56% |
| Apr 3, 2022 | -175.25% |
| Jan 2, 2022 | 8,449.32% |
| Oct 3, 2021 | 54,443.24% |
| Jul 4, 2021 | 35,537.25% |
| Apr 4, 2021 | 18,992.00% |
| Jan 3, 2021 | -52.08% |